The Gluten-Free Brief

June’s gluten-free news: FDA’s labeling review, Virginia’s takeout law, beer testing gaps, a probiotic yeast study, and recalls in three countries.

Celiac disease raises the risk of death, heart disease, and organ failure — and two new studies published this week put the numbers on paper for the first time in the U.S. This edition also covers a landmark labeling bill, a stalled compensation law in Spain, and how major league baseball is stepping up for the celiac community.

Celiac disease raises the risk of eating disorders, a new drug shows effects beyond the gut, and a popular podcast reminded us why awareness still matters. This edition covers the latest research, recalls, and what the celiac community is talking about right now.

The latest edition of The Gluten-Free Brief covers major new celiac research, undiagnosed case estimates from Ireland, Québec, and the UK, gluten-related recalls in Canada, a U.S. court ruling on gluten-free meals, and formulation changes affecting Peanut M&M’s in New Zealand.

How old are celiac risk genes, is kissing after gluten really safe, and which products were just recalled? This edition of the Gluten-Free Brief has the science, the alerts, and the good news.

This edition of The GF Brief looks at why very small gluten doses still matter, what EEGs reveal about sleep in children with celiac disease, how skin conditions like dandruff may connect to celiac, and where policy is moving next on school meals.

Celiac research, screening, and support are moving fast. This edition of The Gluten-Free Brief rounds up key findings and updates.

This edition of The Gluten‑Free Brief covers new celiac research, pancreatitis risk, school screening in Australia, campus advocacy, gluten‑removed beer, and kitchen cross‑contact.

In this edition of The Gluten-Free Brief, we bring you evidence-based updates in policy, science, and access from the UK, Argentina, Spain, and the US.